Pharmafile Logo

Dedicated

- PMLiVE

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Inizio

- PMLiVE

Setting out – why omnichannel success is about orchestration

Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train

- PMLiVE

Roche’s Columvi improves survival in large B-cell lymphoma

Approximately 160,000 people are diagnosed with this aggressive form of cancer each year

- PMLiVE

OPEN Health appoints Diala Habib as president of two of its practices

Habib will be president of Promotional Medical Education and Patient Engagement

- PMLiVE

ISPEP announces inaugural Advisory Board to strengthen global patient engagement leadership

The appointees will guide ISPEP’s not-for-profit organisation strategy and the professionalisation and advancement of patient engagement

- PMLiVE

Unlocking the full potential of healthcare company partnerships

The most successful partnerships overcome both cultural and organisational divides

- PMLiVE

Novo Nordisk presents new findings on semaglutide in Alzheimer’s disease

While the trials did not meet their primary endpoints, they highlighted important biomarker findings

- PMLiVE

Avalere Health appoints Sarah Hall as President of US Marketing

Hall was previously President of FCB Health New York

- PMLiVE

Global regulatory standards

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness

- PMLiVE

Exhibition Trends 2026: What Pharma Exhibitors Need to Know Now

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and build trust. Whether you're launching innovations, strengthening partnerships or showcasing research, the...

Apex Events and Exhibitions

- PMLiVE

Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients

Over 800,000 people worldwide live with haemophilia

- PMLiVE

Gilead’s Yescarta shows benefits for patients with large B-cell lymphoma

This is the most common type of non-Hodgkin lymphoma worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links